ASTRAZENECA PLC (AZN)
Clinical trial NCT06526793 updates: 1. completion date: 2029-06-14 → 2032-10-21 2. primary completion date: 2027-03-10 → 2027-11-24 3. enrollment: 240 → 270 participants
Clinical trial NCT06526793 updates: 1. completion date: 2029-06-14 → 2032-10-21 2. primary completion date: 2027-03-10 → 2027-11-24 3. enrollment: 240 → 270 participants
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical